Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin.
We synthesized several lipid analogues of ganglioside GM1 by attaching its oligosaccharide moiety (GM1OS) to aminophospholipids, aliphatic amines, and cholesteryl hemisuccinate. We incubated GM1-deficient rat glioma C6 cells with each of the derivatives as well as native GM1 and assayed the cells for their ability to bind and respond to cholera toxin. On the basis of the observed increase in binding of 125I-labeled cholera toxin, it was apparent that the cells took up and initially incorporated most of the derivatives into the plasma membrane. In the case of the aliphatic amine derivatives, the ability to generate new toxin binding sites was dependent on chain length; whereas the C10 derivative was ineffective, C12 and higher analogues were effective. Increased binding was dependent on both the concentration of the neoglycolipid in the medium and the time of exposure. Cells pretreated with the various derivatives accumulated cyclic AMP in response to cholera toxin, but there were differences in their effectiveness. The cholesterol and long-chain aliphatic amine derivatives were more effective than native GM1, whereas the phospholipid derivatives were less effective. The distance between GM1OS and the phospholipid also appeared to influence its functional activity. The neoglycolipid formed by cross-linking the amine of GM1OS to phosphatidylethanolamine (PE) with disuccinimidyl suberate was less effective than the neoglycolipid formed by directly attaching GM1OS to PE by reductive amination. Furthermore, insertion of a C8 spacer in the former neoglycolipid rendered it even less effective.(ABSTRACT TRUNCATED AT 250 WORDS)
Pacuszka
T
T
Membrane Biochemistry Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
Bradley
R M
RM
Fishman
P H
PH
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D002738:Chloroquine / Q000494:pharmacology; D002772:Cholera Toxin / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D000242:Cyclic AMP / Q000378:metabolism; D005677:G(M1) Ganglioside / Q000031:analogs & derivatives / Q000378:metabolism*; D006017:Glycolipids / Q000378:metabolism*; D051381:Rats; D014407:Tumor Cells, Cultured
D006017:Glycolipids; D005677:G(M1) Ganglioside; D002738:Chloroquine; D002772:Cholera Toxin; D000242:Cyclic AMP; D000262:Adenylyl Cyclases